This one-day event focuses the intersection of precision medicine, oncology, and big data.  Dr. Beth Anne Baber, Founder and CEO of STORM Real World Health, will be moderating a dynamic panel discussion on the local industry’s perspective on precision medicine and the vital role San Diego is playing in our Nation’s largest population health study, the All of Us Research Program. This initiative will gather biological, lifestyle, and environment data from one million people living in the United States.  Members of the panel include:
• Dawn Barry, VP of Applied Genomics at Illumina
• Camille Nebeker, Assistant Professor at University of California- San Diego
• David Wellis, CEO of the San Diego Blood Bank. 

Dr. Stephanie Devaney, Deputy Director the All of Us Research Program at National Institutes of Health, will deliver the opening keynote on where precision medicine is heading. Kaiser Permanente’s Assistant Medical Director and Chief Health Information Officer, Dr. John Mattison, will end the day on the economics of precision medicine. Other topics include cancer treatment decision-support, data integration and utility, analytics and reimbursement.   

If you are attending this event and want to connect, please email Dr. Baber at [email protected].
​
For more information on the BIOCOM Big Data Executive Summit, visit biocom.org. https://www.biocom.org/s/EventDetail?event=Big-Data-2017

Dr. Beth Anne Baber, Founder and CEO of STORM Real World Health, will attend the 13th California Initiative to Advance Precision Medicine (CIAPM) in San Diego on October 12 and 13, 2017. This year's conference will focus on data generation, data security, and data sharing. If you are attending this conference and want to connect, please email Dr. Baber at [email protected] or you can find her on LinkedIn at https://www.linkedin.com/in/bethannebaber/.

For more information on CIAPM, visit ciapm.org.